Men's Health

Top Story

Biomarkers may guide personalized therapy for castration-resistant prostate cancer

June 27, 2017

Assessment of androgen receptor gene status in plasma DNA identified patients with castration-resistant prostate cancer with worse outcomes to standard therapy, according to a multi-institution correlative biomarker study.

Standard treatment for castration-resistant prostate cancer involves inhibition of androgen receptor signaling with abiraterone (Zytiga, Janssen) or enzalutamide (Xtandi; Astellas, Medivation).

In the Journals

Cryotherapy may be used as first-line therapy for anogenital warts

June 27, 2017
Cryotherapy did not differ in efficacy from other treatments for anogenital warts, and could be used as first-line therapy, according to recently published study results…

Multimodal therapy eliminates detectable disease in early metastatic prostate cancer

June 27, 2017
Aggressive multimodal therapy appeared to eliminate all detectable disease among certain patients with early metastatic prostate cancer, according to study results…
In the Journals

Deployment stress affects men, women differently

June 26, 2017
Recent findings indicated associations between deployment stressors and functioning in work and family following military service, with depression playing an important…
In the Journals Plus

Biomarkers may guide personalized therapy for castration-resistant prostate cancer

June 27, 2017
Assessment of androgen receptor gene status in plasma DNA identified patients with castration-resistant prostate cancer with worse outcomes to…

In the Journals

Cryotherapy may be used as first-line therapy for anogenital warts

June 27, 2017
Cryotherapy did not differ in efficacy from other treatments for anogenital warts, and could be used as first-line therapy, according to recently…

Multimodal therapy eliminates detectable disease in early metastatic prostate cancer

June 27, 2017
Aggressive multimodal therapy appeared to eliminate all detectable disease among certain patients with early metastatic prostate cancer, according to…

In the Journals

Deployment stress affects men, women differently

June 26, 2017
Recent findings indicated associations between deployment stressors and functioning in work and family following military service, with depression…

Meeting News

Barriers to HPV vaccine uptake identified, suggestions to overcome such obstacles offered

June 23, 2017
PHILADELPHIA — HPV vaccine rates in 2015 were below the Healthy People 2020 target of 80%, suggesting an opportunity for nurse practitioners…

In the Journals

Gender-based pricing shown for minoxidil for hair loss

June 21, 2017
Women were charged more per dose for minoxidil, 5%, foam for androgenetic alopecia when compared with products marketed for men, according to…

Meeting News

Guest Commentary: STAMPEDE trial provides exciting results, questions in prostate cancer treatment

June 21, 2017
In this guest commentary, Terence Friedlander, MD, discusses the benefits associated with the addition of

Meeting NewsVideo

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
CHICAGO — The results of the LATITUDE trial demonstrated that the addition of abiraterone acetate with prednisone to standard hormonal therapy…

Meeting NewsVideo

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
CHICAGO — The use of sipuleucel-T in patients with hormone-sensitive and castration-resistant prostate cancer demonstrated an increase in the…

In the Journals Plus

Men with prostate cancer willing to pay more for advanced biopsies

June 15, 2017
Men with prostate cancer paid up to $2,000 out of health savings accounts for magnetic resonance imaging–transrectal ultrasound…

More Headlines »
Advertisement
Advertisement